RU2008142658A - METHOD FOR TREATING INFECTIOUS DISEASES OF THE NERVOUS SYSTEM - Google Patents
METHOD FOR TREATING INFECTIOUS DISEASES OF THE NERVOUS SYSTEM Download PDFInfo
- Publication number
- RU2008142658A RU2008142658A RU2008142658/14A RU2008142658A RU2008142658A RU 2008142658 A RU2008142658 A RU 2008142658A RU 2008142658/14 A RU2008142658/14 A RU 2008142658/14A RU 2008142658 A RU2008142658 A RU 2008142658A RU 2008142658 A RU2008142658 A RU 2008142658A
- Authority
- RU
- Russia
- Prior art keywords
- nervous system
- tactivin
- heparin
- administered
- body weight
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 3
- 210000000653 nervous system Anatomy 0.000 title claims abstract 3
- 208000035473 Communicable disease Diseases 0.000 title 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims abstract 4
- 108010044279 T-activin Proteins 0.000 claims abstract 4
- 230000037396 body weight Effects 0.000 claims abstract 4
- 229960002897 heparin Drugs 0.000 claims abstract 4
- 229920000669 heparin Polymers 0.000 claims abstract 4
- 206010037660 Pyrexia Diseases 0.000 claims abstract 2
- 230000027950 fever generation Effects 0.000 claims abstract 2
- 208000015181 infectious disease Diseases 0.000 claims abstract 2
- 230000002458 infectious effect Effects 0.000 claims abstract 2
- 230000003902 lesion Effects 0.000 claims abstract 2
- 230000001717 pathogenic effect Effects 0.000 claims abstract 2
- 238000002560 therapeutic procedure Methods 0.000 claims abstract 2
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способ патогенетического лечения инфекционных поражений нервной системы, отличающийся тем, что наряду с классической терапией используют гепарин и тактивин, гепарин вводят по 150 ЕД/кг массы тела в сутки шестикратно внутривенно в течение периода пирексии, тактивин вводят в стандартной дозе по 2 мкг на 1 кг массы тела подкожно однократно в сутки в течение 5 дней. A method for the pathogenetic treatment of infectious lesions of the nervous system, characterized in that, along with classical therapy, heparin and tactivin are used, heparin is administered at 150 IU / kg of body weight per day six times intravenously during the period of pyrexia, tactivin is administered in a standard dose of 2 μg per 1 kg body weight subcutaneously once a day for 5 days.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2008142658/14A RU2008142658A (en) | 2008-10-27 | 2008-10-27 | METHOD FOR TREATING INFECTIOUS DISEASES OF THE NERVOUS SYSTEM |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2008142658/14A RU2008142658A (en) | 2008-10-27 | 2008-10-27 | METHOD FOR TREATING INFECTIOUS DISEASES OF THE NERVOUS SYSTEM |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2008142658A true RU2008142658A (en) | 2010-05-10 |
Family
ID=42673354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008142658/14A RU2008142658A (en) | 2008-10-27 | 2008-10-27 | METHOD FOR TREATING INFECTIOUS DISEASES OF THE NERVOUS SYSTEM |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2008142658A (en) |
-
2008
- 2008-10-27 RU RU2008142658/14A patent/RU2008142658A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2021050953A8 (en) | Compositions and methods for the delivery of therapeutic biologics for treatment of disease | |
| MX336710B (en) | Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases. | |
| PT2484365E (en) | Compositions and method for treatment of neovascular diseases | |
| WO2006102596A3 (en) | Dosage regimen for the treatment of a traumatic brain injury with progesterone | |
| WO2008039898A3 (en) | Methods for the treatment of a traumatic central nervous system injury | |
| MX2019013279A (en) | Methods of treating doose syndrome using fenfluramine. | |
| IL171607A (en) | Use of a botulinum toxin for the preparation of a medicament for treating sinus headache | |
| IL189546A0 (en) | Therapy for the treatment of disease | |
| HK1202776A1 (en) | Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy | |
| NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
| JP2018526460A5 (en) | ||
| WO2006014159A3 (en) | Methods of using regenerative cells in the treatment of musculoskeletal disorders | |
| MA34547B1 (en) | ASSOCIATION TREATMENT FOR TREATING HCV INFECTION | |
| MX2009003532A (en) | Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin. | |
| MX2018000240A (en) | Methods for treating hcv. | |
| MX2022012001A (en) | Preventative treatment of migraine. | |
| MX2016012722A (en) | Methods for treating hcv. | |
| EA201270298A1 (en) | METHOD OF TREATMENT OF MALIGNANT TUMOR | |
| GB0405381D0 (en) | A method and means for treating heart failure | |
| MX2022011171A (en) | Compounds with immunomodulatory activity and therapeutic uses thereof. | |
| RU2008142658A (en) | METHOD FOR TREATING INFECTIOUS DISEASES OF THE NERVOUS SYSTEM | |
| MX2021008986A (en) | Methods of treating a patient having parkinson's disease. | |
| EA202190724A1 (en) | KETAMINE-BASED PREPARATION FOR TREATMENT OF DEPRESSION BY INHALATION | |
| DE602006020838D1 (en) | MEDICAMENTS FOR PREVENTING OR TREATING HEART FAILURE WITH AN ANTICHOLINERGICUM | |
| RU2007100833A (en) | METHOD FOR TREATING INFECTIOUS FACILITY OF THE FACIAL NERVE IN THE ACUTE PERIOD |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20121030 |